Retatrutide, a novel dual stimulator of the GLP-1 target and glucose-dependent released polypeptide (GIP) receptor , is demonstrating promising results in initial clinical trials . Current research https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/